• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Sempre Health Launches Behavior-based Healthcare Pricing Platform for Patients

by Our Thought Leaders 07/17/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Sempre Health

Sempre Health, a San Francisco, CA-based startup has officially launched a new behavior-based healthcare pricing platform that empowers consumers to lower their own medication costs over time. Founded in 2015, Sempre works with health plans and pharma manufacturers to dynamically adjust any patient’s co-payment based on individual adherence and behavior, seamlessly at the point of fill.

Matching the right patient to the right price for the right therapy is a data problem, and in the 21st century, price should no longer be “one size fits all”. All people with a given health plan have the same deductibles and copayments, regardless of individual behaviors or specific clinical needs. At the same time, 1 in 3 patients has skipped or delayed medically necessary care because of cost. These patients go on to be less healthy and more expensive to the health system and its payers.

After graduating the Alchemist Accelerator and concluding a favorable randomized controlled trial in 2016, Sempre Health is now partnering with a large regional health plan. This Sempre program will enroll heart patients and engage them over SMS, using the principles of behavioral economics to incentivize healthy decision-making.

Behavior-based, Dynamic Pricing Overview

Similar to a “good driver discount” with car insurance, if a patient is adherent and takes her medications regularly, she will pay less when filling her prescriptions. Patients can bring their own costs down over time, thereby supporting long-term behavior change and saving healthcare dollars, while addressing affordability in a unique way. Sempre’s technology parses millions of prescription records to predict the right price, for the right patient, at the right time. Then their data integrations deliver that price at any pharmacy in the US. Via SMS, patients have 24/7 access to their current discounts, why they got those discounts and guidance on how to improve.

“Patients who are committed to making healthy choices improve their own outcomes and bring significant savings to the system, yet they rarely get any financial benefit for doing the right thing. What kind of healthy behaviors might we have if it weren’t expensive to have them?”, said Anurati Mathur, Sempre Health CEO in a statement. “With Sempre, your behavior is currency, and it counts towards the health expenses you face every day.”

 

Sempre recently raised a $2.5M seed round last year from Social Capital, a top-tier Silicon Valley investor in consumer healthcare. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Sempre Health

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |